Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer

<div>Preoperative Kisspeptin concentrations do not reflect the patients’ prognosis following PDAC resection. (a) The 50<sup>th</sup> percentile (159.75 pg/ml) of preoperative Kisspeptin serum levels is no suitable discriminator to identify patients who display long-term survival. (b) The optimal preoperative Kisspeptin cut-off value (234.0 pg/ml) is no discriminator between patients who display long-term survival and those who did not.</div>

Disease Markers

fig2

Figure 2

Figure 2: Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer 